Home > Products > EGFR & MET
> Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (Diabody-CH3)
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (Diabody-CH3) (CAT#: BSDBC-154)
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (Diabody-CH3) is a fusion protein of two diabodies connected together by a CH3 region. In a diabody, the two scFvs with short linkers are from anti-EGFR and anti-MET antibodies. The VH and VL domains form an inter-chain pairing. The diabody with different specificities is fused to each of the CH3 chains, which results in 2+2 antigen-binding valency and extends the half-life of this BsAb. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Colorectal cancer; Pancreatic cancer; Head and neck cancer; Non-small cell lung cancer (NSCLC) therapy.
There are currently no customer reviews or questions for Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (Diabody-CH3) (BSDBC-154). Click the button below to contact us or submit your feedback about this product.